Proteome Sciences plc (LON:PRM – Get Free Report) was down 15.1% on Tuesday . The stock traded as low as GBX 2.35 ($0.03) and last traded at GBX 2.35 ($0.03). Approximately 343,488 shares traded hands during mid-day trading, an increase of 117% from the average daily volume of 158,279 shares. The stock had previously closed at GBX 2.77 ($0.04).
Proteome Sciences Stock Down 16.4 %
The business has a 50 day moving average price of GBX 2.84 and a 200-day moving average price of GBX 3.32. The firm has a market cap of £6.79 million, a price-to-earnings ratio of -277.50 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- Best Aerospace Stocks Investing
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What is the Australian Securities Exchange (ASX)
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What to Know About Investing in Penny Stocks
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
